Kristel Van Laethem
AuthID: R-006-TPJ
81
TITLE: Anti-human immunodeficiency virus drug combination strategies
AUTHORS: Vandamme, AM; Van Vaerenbergh, K; De Clercq, E;
PUBLISHED: 1998, SOURCE: ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, VOLUME: 9, ISSUE: 3
AUTHORS: Vandamme, AM; Van Vaerenbergh, K; De Clercq, E;
PUBLISHED: 1998, SOURCE: ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, VOLUME: 9, ISSUE: 3
INDEXED IN: 
Scopus 
WOS
Scopus WOS82
TITLE: Diagnosis of human immunodeficiency virus infection by a polymerase chain reaction assay evaluated in patients harbouring strains of diverse geographical origin Full Text
AUTHORS: Van Laethem, K; Beuselinck, K; Van Dooren, S; De Clercq, E; Desmyter, J; Vandamme, AM;
PUBLISHED: 1998, SOURCE: JOURNAL OF VIROLOGICAL METHODS, VOLUME: 70, ISSUE: 2
AUTHORS: Van Laethem, K; Beuselinck, K; Van Dooren, S; De Clercq, E; Desmyter, J; Vandamme, AM;
PUBLISHED: 1998, SOURCE: JOURNAL OF VIROLOGICAL METHODS, VOLUME: 70, ISSUE: 2
83
TITLE: Anti-HIV virus combination therapy and resistance management
AUTHORS: Vandamme, AM; Van Laethem, K; Van Vaerenbergh, K; De Clercq, E;
PUBLISHED: 1998, SOURCE: International Antiviral News, VOLUME: 6, ISSUE: 10
AUTHORS: Vandamme, AM; Van Laethem, K; Van Vaerenbergh, K; De Clercq, E;
PUBLISHED: 1998, SOURCE: International Antiviral News, VOLUME: 6, ISSUE: 10
INDEXED IN: Scopus
Scopus84
TITLE: Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug users Full Text
AUTHORS: Salemi, M; Vandamme, AM; Gradozzi, C; Van Laethem, K; Cattaneo, E; Taylor, G; Casoli, C; Goubau, P; Desmyter, J; Bertazzoni, U;
PUBLISHED: 1998, SOURCE: JOURNAL OF MOLECULAR EVOLUTION, VOLUME: 46, ISSUE: 5
AUTHORS: Salemi, M; Vandamme, AM; Gradozzi, C; Van Laethem, K; Cattaneo, E; Taylor, G; Casoli, C; Goubau, P; Desmyter, J; Bertazzoni, U;
PUBLISHED: 1998, SOURCE: JOURNAL OF MOLECULAR EVOLUTION, VOLUME: 46, ISSUE: 5
85
TITLE: Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries
AUTHORS: Schmit, JC; Van Laethem, K; Ruiz, L; Hermans, P; Sprecher, S; Sonnerborg, A; Leal, M; Harrer, T; Clotet, B; Arendt, V; Lissen, E; Witvrouw, M; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLISHED: 1998, SOURCE: AIDS, VOLUME: 12, ISSUE: 15
AUTHORS: Schmit, JC; Van Laethem, K; Ruiz, L; Hermans, P; Sprecher, S; Sonnerborg, A; Leal, M; Harrer, T; Clotet, B; Arendt, V; Lissen, E; Witvrouw, M; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLISHED: 1998, SOURCE: AIDS, VOLUME: 12, ISSUE: 15
86
TITLE: Phenotypic assays and sequencing are less sensitive for the detection of resistance in mixed genotypes compared to point mutation assays.
AUTHORS: Van Laethem, K; Van Vaerenbergh, K; Schmit, JC; Sprecher, S; Hermans, P; De Vroye, V; Schuurman, R; Harrer, T; Witvrouw, M; Van Wijngaerden, E; De Clercq, E; Desmyter, J; Vandamme, AM;
PUBLISHED: 1998, SOURCE: AIDS, VOLUME: 12
AUTHORS: Van Laethem, K; Van Vaerenbergh, K; Schmit, JC; Sprecher, S; Hermans, P; De Vroye, V; Schuurman, R; Harrer, T; Witvrouw, M; Van Wijngaerden, E; De Clercq, E; Desmyter, J; Vandamme, AM;
PUBLISHED: 1998, SOURCE: AIDS, VOLUME: 12
INDEXED IN: WOS
WOS87
TITLE: Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent Simian strains in the evaluation of individuals with indeterminate HTLV serology Full Text
AUTHORS: Vandamme, AM; VanLaethem, K; Liu, HF; VanBrussel, M; Delaporte, E; Costa, CMDC; Fleischer, C; Taylor, G; Bertazzoni, U; Desmyter, J; Goubau, P;
PUBLISHED: 1997, SOURCE: JOURNAL OF MEDICAL VIROLOGY, VOLUME: 52, ISSUE: 1
AUTHORS: Vandamme, AM; VanLaethem, K; Liu, HF; VanBrussel, M; Delaporte, E; Costa, CMDC; Fleischer, C; Taylor, G; Bertazzoni, U; Desmyter, J; Goubau, P;
PUBLISHED: 1997, SOURCE: JOURNAL OF MEDICAL VIROLOGY, VOLUME: 52, ISSUE: 1
